{"gene":"PDE6B","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2010,"finding":"PDE6A and PDE6B catalytic subunits are enzymatically equivalent: chimeric homodimeric enzymes containing the PDE6A or PDE6B catalytic domain (expressed in transgenic Xenopus laevis) hydrolyzed cGMP with similar Km (~20–23 µM) and kcat (~4200–5100 s⁻¹) values, and were similarly inhibited by both cone- and rod-specific Pγ subunits. Both were fully activated by recombinant cone transducin-α and native rod Gαt1. In contrast, bovine rod PDE6 heterodimer required markedly higher transducin concentrations for half-maximal activation, indicating the PDE6A/PDE6B heterodimer differs from PDE6C homodimers specifically in its interaction with transducin, not in its catalytic properties or Pγ interactions.","method":"Transgenic Xenopus laevis expression of chimeric EGFP-PDE6C-A and EGFP-PDE6C-B; selective immunoprecipitation; in vitro cGMP hydrolysis assays; kinetic analysis (Km, kcat); inhibition assays with Pγ subunits; activation assays with Gαt1 and Gαt2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic reconstitution with kinetic characterization, multiple orthogonal assays (Km, kcat, Pγ inhibition, transducin activation), in vivo expression in transgenic animals","pmids":["20940301"],"is_preprint":false},{"year":2007,"finding":"The H258N missense mutation in PDE6B causes congenital stationary night blindness (CSNB) rather than progressive retinitis pigmentosa. Transgenic mice carrying H258N showed an approximately 3-fold increase in cGMP hydrolysis rate (from 130.1 to 319.2 nmol·min⁻¹·nmol⁻¹ rhodopsin in dark-adapted retinas), consistent with the hypothesis that the H258N mutation blocks inhibition of PDE6B activity by the regulatory PDE6γ subunit. ERG phenotype (selective loss of b-wave with relatively normal a-wave) mirrored that of human CSNB patients.","method":"Transgenic mouse generation (H258N allele); dark-adapted cGMP-PDE6 enzymatic activity assay on retinal homogenates; electroretinography; histology and photoreceptor cell counting","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic assay with quantitative measurement, transgenic model with functional ERG validation, mechanistic interpretation supported by biochemical and physiological data","pmids":["17044014"],"is_preprint":false},{"year":2005,"finding":"In rd1 mouse retinas, phosducin (a regulator of G-protein signaling in photoreceptors) shows aberrant hyperphosphorylation irrespective of light/dark status, in contrast to wild-type retinas where phosducin is highly phosphorylated only in the dark. This hyperphosphorylation coincides with constitutive activation of Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) in rd1 rod outer segments. The elevated CaMKII activity is consistent with the known increase in intracellular calcium caused by the Pde6b mutation (failure to hydrolyze cGMP → persistent opening of cGMP-gated channels → Ca²⁺ overload), implicating CaMKII overactivation as an early step in photoreceptor degeneration.","method":"2D gel electrophoresis proteomics; mass spectrometry protein identification; immunoblotting with phospho-specific antibodies; immunohistochemistry; light/dark adaptation experiments in rd1 and wild-type mice","journal":"Molecular & cellular proteomics : MCP","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (proteomics, immunoblotting, IHC, light/dark paradigm) in a single lab; mechanistic link to elevated calcium from Pde6b mutation is inferred but biochemically consistent","pmids":["16253986"],"is_preprint":false},{"year":2006,"finding":"Calpain protease is activated in degenerating rd1 photoreceptors at postnatal day 13, coinciding with peak photoreceptor cell death. Calpastatin (endogenous calpain inhibitor) expression is reduced in rd1 retinas, while calpain activity is substantially elevated, demonstrable by an enzymatic in situ assay. Calpain-specific inhibitors decreased calpain activity in situ, implicating calcium-dependent calpain activation as a mediator of photoreceptor cell death downstream of the elevated intracellular Ca²⁺ caused by loss of PDE6B-mediated cGMP hydrolysis.","method":"Microarray transcriptome analysis; immunofluorescence; immunoblotting; in situ enzymatic calpain activity assay; pharmacological inhibition with calpain inhibitors","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic activity assay with pharmacological intervention, multiple methods (microarray, IHC, western blot, in situ assay), single lab","pmids":["16405498"],"is_preprint":false},{"year":2015,"finding":"A confounding mutation in Gpr179 (encoding a G-protein coupled receptor on ON-bipolar cell dendrites) in the rd1 mouse strain prevents full restoration of the ERG b-wave after AAV-mediated PDE6B gene supplementation. After backcrossing rd1 mice onto a C57BL/6 background to eliminate the Gpr179 mutation, gene replacement of PDE6B restored both the photoreceptor-mediated a-wave and the bipolar cell-mediated b-wave, with preservation for up to 13 months. This demonstrates that PDE6B gene therapy can rescue both photoreceptor function and downstream bipolar cell signaling when no secondary mutations are present.","method":"AAV-mediated gene therapy in rd1 mice; electroretinography (a-wave and b-wave measurement); genetic backcrossing; Sanger sequencing/genotyping for Gpr179 mutation; in vivo longitudinal follow-up","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function/gain-of-function genetic experiment with defined molecular and functional phenotypic readout; gene replacement with long-term ERG follow-up; replicated across genetic backgrounds","pmids":["25613321"],"is_preprint":false},{"year":1995,"finding":"Two probands with autosomal recessive retinitis pigmentosa were found to carry compound heterozygous mutations in the PDE6B gene: one with Gly576Asp and His620(1-bp deletion), the other with Lys706X (nonsense) and an AG→AT splice acceptor site mutation in intron 2. These are the first mutations in the human PDE6B gene established as causative for autosomal recessive RP, confirming PDE6B as a disease gene for this condition.","method":"Haplotype analysis with dinucleotide repeat polymorphism; DGGE and SSCP electrophoresis of all 22 PDE6B exons; DNA sequencing; cosegregation analysis in families","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cosegregation of compound heterozygous mutations with disease in two independent families; multiple mutation types including a nonsense mutation; single lab","pmids":["8595886"],"is_preprint":false},{"year":2000,"finding":"A null mutation (8-bp insertion after codon 816) in the PDE6B gene cosegregates with generalized progressive retinal atrophy (gPRA) in Sloughi dogs, establishing PDE6B mutation as the cause of this canine retinal degeneration. PDE6B was excluded as a candidate gene for gPRA in 11 other dog breeds by detecting heterozygous allele constellations in affected animals.","method":"Genomic library isolation of canine PDE6B; SSCP analysis; cosegregation analysis in a large Sloughi pedigree; exclusion analysis in 11 other breeds","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutation cosegregation in large pedigree, functional inference from insertion causing frameshift; single lab","pmids":["11124530"],"is_preprint":false},{"year":2013,"finding":"A 3-base deletion in exon 21 of canine PDE6B causes early-onset retinal degeneration (crd1) in American Staffordshire Terriers, with structural photoreceptor abnormalities detectable as early as 11 weeks of age affecting both rod and cone inner and outer segments. This was identified by GWAS mapping to CFA3 followed by candidate gene sequencing.","method":"GWAS with Illumina Canine SNP array; candidate gene sequencing; retinal morphology by light microscopy; PLINK association analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GWAS plus direct sequencing with cosegregation; histological phenotype characterization; single lab","pmids":["24045995"],"is_preprint":false},{"year":2022,"finding":"Multiomics analysis of neonatal and developing Pde6brd1/rd1 rods before the onset of degeneration revealed early downregulation of anabolic and energy metabolism genes, early changes in calcium signaling and oxidative phosphorylation (with specific partial bypass of complex I electron transfer), and dysregulation of glycolysis, pentose phosphate, and purine biosynthesis pathways. Transmission electron microscopy and ex vivo oxygen consumption assays validated progressive mitochondrial structural abnormalities and functional deficits in rd1 rods. Aberrant calcium signaling is implicated as an initiator of mitochondrial stress, establishing mitochondrial damage and metabolic disruption as early drivers of photoreceptor cell death caused by PDE6B loss.","method":"Transcriptome profiling (RNA-seq) of neonatal/developing rods; quantitative proteomics; metabolomics; transmission electron microscopy; ex vivo oxygen consumption assays; temporal analysis before onset of degeneration","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal omics methods plus ultrastructural and functional validation, temporal analysis preceding cell death onset, mechanistic pathway placement","pmids":["35075486"],"is_preprint":false},{"year":2010,"finding":"HDAC class I/II overactivation temporally precedes photoreceptor degeneration in rd1 retinas. Using a custom in situ HDAC activity assay, histone acetylation was found dramatically reduced in degenerating rd1 photoreceptors. Pharmacological inhibition of HDAC I/II activity in rd1 organotypic retinal explants decreased PARP activity and strongly reduced photoreceptor cell death, establishing excessive HDAC activation as a mechanistically important step in the cell death pathway downstream of PDE6B loss.","method":"Custom in situ HDAC activity assay; immunofluorescence for histone acetylation; pharmacological HDAC I/II inhibition in organotypic retinal explants; PARP activity assay; TUNEL cell death quantification","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in situ enzymatic assay, pharmacological intervention with defined molecular and cellular readout, organotypic explant system; single lab","pmids":["21364632"],"is_preprint":false},{"year":2008,"finding":"A missense mutation p.W807R in the PDE6B gene was identified and shown to cosegregate with autosomal recessive retinitis pigmentosa in a consanguineous Tunisian family, distinct from USH2 syndrome in the same family caused by a GPR98 mutation. This demonstrates that W807R in PDE6B is a pathogenic variant causing non-syndromic arRP.","method":"Linkage analysis with flanking PDE6B markers (D4S3360 and D4S2930); molecular sequencing; cosegregation analysis in an extended consanguineous family","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cosegregation with flanking markers and direct sequencing; single lab, single family","pmids":["18854872"],"is_preprint":false}],"current_model":"PDE6B encodes the beta catalytic subunit of rod photoreceptor cGMP phosphodiesterase 6 (PDE6), which is enzymatically equivalent to PDE6A in catalytic properties and Pγ-subunit interactions but differs in transducin interaction; loss-of-function mutations abolish cGMP hydrolysis in the phototransduction cascade, leading to cGMP accumulation, persistent cGMP-gated channel opening, calcium overload, constitutive CaMKII activation, aberrant phosducin hyperphosphorylation, calpain activation, HDAC overactivation, and early mitochondrial stress/metabolic disruption that collectively drive rod photoreceptor apoptosis; gain-of-function H258N mutation blocks PDE6γ inhibition, causing CSNB; and AAV-mediated PDE6B gene replacement restores both photoreceptor and bipolar cell function when confounding secondary mutations are absent."},"narrative":{"mechanistic_narrative":"PDE6B encodes the beta catalytic subunit of rod photoreceptor cGMP phosphodiesterase, the effector enzyme of the phototransduction cascade that hydrolyzes cGMP to terminate the light response [PMID:20940301]. The PDE6B catalytic domain is enzymatically equivalent to PDE6A—reconstituted chimeric homodimers hydrolyze cGMP with comparable Km and kcat and are similarly inhibited by the regulatory Pγ subunit and activated by transducin-α—with the rod PDE6A/PDE6B heterodimer distinguished from cone PDE6C chiefly by its requirement for higher transducin concentrations for activation [PMID:20940301]. Loss-of-function mutations in PDE6B cause autosomal recessive retinitis pigmentosa in humans and analogous retinal degenerations in dogs, with disease-causing nonsense, frameshift, splice, and missense alleles identified across multiple families and breeds [PMID:8595886, PMID:11124530, PMID:24045995, PMID:18854872]. Failure to hydrolyze cGMP keeps cGMP-gated channels open, producing calcium overload that drives a cascade of downstream effectors—constitutive CaMKII activation with aberrant phosducin hyperphosphorylation [PMID:16253986], calpain protease activation with reduced calpastatin [PMID:16405498], class I/II HDAC overactivation that precedes cell death [PMID:21364632], and early mitochondrial structural and metabolic disruption [PMID:35075486]—that collectively execute photoreceptor apoptosis. In contrast, the gain-of-function H258N mutation increases cGMP hydrolysis ~3-fold by blocking Pγ inhibition and causes congenital stationary night blindness rather than progressive degeneration [PMID:17044014]. AAV-mediated PDE6B gene replacement restores both the photoreceptor a-wave and the bipolar-cell b-wave when confounding secondary mutations are absent [PMID:25613321].","teleology":[{"year":1995,"claim":"Establishing PDE6B as a human disease gene answered whether mutations in the rod PDE beta subunit are causative for inherited retinal degeneration.","evidence":"DGGE/SSCP screening and sequencing of all 22 exons with cosegregation in two arRP families carrying compound heterozygous mutations","pmids":["8595886"],"confidence":"Medium","gaps":["No functional demonstration of how each allele impairs cGMP hydrolysis","Single lab, two families"]},{"year":2000,"claim":"A null frameshift allele cosegregating with canine gPRA confirmed PDE6B loss-of-function as causative across species and validated a large-animal model.","evidence":"SSCP and cosegregation analysis in a Sloughi pedigree plus exclusion in 11 other breeds","pmids":["11124530"],"confidence":"Medium","gaps":["No biochemical characterization of the truncated protein","Breed-specific allele"]},{"year":2005,"claim":"Identifying aberrant phosducin hyperphosphorylation and constitutive CaMKII activation began to define the calcium-driven signaling consequences of PDE6B loss.","evidence":"2D-gel proteomics, mass spectrometry, phospho-immunoblotting and IHC with light/dark adaptation in rd1 versus wild-type mice","pmids":["16253986"],"confidence":"Medium","gaps":["Link to elevated calcium inferred, not directly perturbed","Causal role in cell death not tested"]},{"year":2006,"claim":"Demonstrating calpain activation downstream of calcium overload identified a protease effector arm of the degeneration pathway.","evidence":"In situ enzymatic calpain assay with calpastatin measurement and pharmacological calpain inhibition in rd1 retinas","pmids":["16405498"],"confidence":"Medium","gaps":["Inhibition reduced activity but rescue of cell survival not quantified here","Calpain substrates in photoreceptors not identified"]},{"year":2007,"claim":"The H258N transgenic model resolved why one PDE6B allele causes stationary night blindness rather than progressive RP—by showing a gain-of-function increase in cGMP hydrolysis.","evidence":"Transgenic mice with dark-adapted cGMP-PDE enzymatic assays, ERG, and histology","pmids":["17044014"],"confidence":"High","gaps":["Structural basis of impaired Pγ inhibition not resolved","Mechanism of selective b-wave loss not detailed"]},{"year":2010,"claim":"In vitro reconstitution of chimeric catalytic domains established that PDE6A and PDE6B are catalytically equivalent and that the rod enzyme differs from cone PDE6 in transducin interaction, not catalysis or Pγ regulation.","evidence":"Transgenic Xenopus expression of EGFP-PDE6C-A/-B chimeras with kinetic (Km, kcat), Pγ inhibition, and transducin activation assays","pmids":["20940301"],"confidence":"High","gaps":["Structural basis of the transducin interaction difference unknown","Behavior of the native A/B heterodimer versus chimeric homodimers"]},{"year":2010,"claim":"Showing HDAC class I/II overactivation preceding cell death and rescuable by HDAC inhibition placed epigenetic dysregulation within the degeneration cascade.","evidence":"Custom in situ HDAC activity assay, histone acetylation IHC, and pharmacological HDAC inhibition in rd1 organotypic explants with PARP and TUNEL readouts","pmids":["21364632"],"confidence":"Medium","gaps":["Specific HDAC isoform and target genes not identified","Connection to upstream calcium signaling not directly tested"]},{"year":2013,"claim":"A canine exon-21 deletion causing early-onset rod and cone degeneration extended the disease spectrum of PDE6B mutations to early structural photoreceptor defects.","evidence":"GWAS mapping to CFA3, candidate sequencing, and retinal morphology in American Staffordshire Terriers","pmids":["24045995"],"confidence":"Medium","gaps":["Why a rod-PDE gene defect affects cone segments not mechanistically explained","No biochemical assay of the mutant protein"]},{"year":2015,"claim":"AAV gene replacement demonstrated PDE6B therapeutic rescue and clarified that a confounding Gpr179 mutation, not the therapy, limited bipolar-cell recovery.","evidence":"AAV-PDE6B supplementation in rd1 mice with a- and b-wave ERG, genetic backcrossing to remove Gpr179, and 13-month longitudinal follow-up","pmids":["25613321"],"confidence":"High","gaps":["Durability and dosing in larger eyes not addressed","Therapeutic window relative to degeneration stage not defined"]},{"year":2022,"claim":"Pre-degeneration multiomics established that mitochondrial stress and metabolic disruption are early drivers, not late consequences, of PDE6B loss.","evidence":"RNA-seq, proteomics, metabolomics, transmission EM, and ex vivo oxygen consumption in neonatal/developing rd1 rods before degeneration onset","pmids":["35075486"],"confidence":"High","gaps":["Causal sequence from calcium signaling to mitochondrial failure not directly perturbed","Whether metabolic intervention prevents degeneration not tested"]},{"year":null,"claim":"How the parallel calcium-dependent effector arms (CaMKII/phosducin, calpain, HDAC, mitochondrial/metabolic) are causally ordered and integrated into the final apoptotic decision remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No epistatic test ranking the effector pathways","No structural model of the PDE6A/PDE6B/Pγ/transducin assembly in the timeline","Translation of combined-pathway intervention to therapy unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,1,4]}],"complexes":["Rod cGMP phosphodiesterase 6 (PDE6) holoenzyme"],"partners":["PDE6A","PDE6G","GNAT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35913","full_name":"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta","aliases":[],"length_aa":854,"mass_kda":98.3,"function":"Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). Necessary for the formation of a functional phosphodiesterase holoenzyme (By similarity). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity). May participate in processes of transmission and amplification of the visual signal (PubMed:8394174)","subcellular_location":"Membrane; Cell projection, cilium, photoreceptor outer segment","url":"https://www.uniprot.org/uniprotkb/P35913/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDE6B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDE6B","total_profiled":1310},"omim":[{"mim_id":"614515","title":"G PROTEIN-COUPLED RECEPTOR 179; GPR179","url":"https://www.omim.org/entry/614515"},{"mim_id":"613810","title":"RETINITIS PIGMENTOSA 43; RP43","url":"https://www.omim.org/entry/613810"},{"mim_id":"613801","title":"RETINITIS PIGMENTOSA 40; RP40","url":"https://www.omim.org/entry/613801"},{"mim_id":"613596","title":"FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A; FAM161A","url":"https://www.omim.org/entry/613596"},{"mim_id":"613582","title":"RETINITIS PIGMENTOSA 57; RP57","url":"https://www.omim.org/entry/613582"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Basal body","reliability":"Uncertain"},{"location":"Cytosol","reliability":"Uncertain"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":357.2}],"url":"https://www.proteinatlas.org/search/PDE6B"},"hgnc":{"alias_symbol":["CSNB3","rd1","RP40","CSNBAD2"],"prev_symbol":["PDEB"]},"alphafold":{"accession":"P35913","domains":[{"cath_id":"3.30.450.40","chopping":"70-230","consensus_level":"high","plddt":92.7581,"start":70,"end":230},{"cath_id":"3.30.450.40","chopping":"250-369_379-439","consensus_level":"high","plddt":91.9929,"start":250,"end":439},{"cath_id":"1.10.1300.10","chopping":"463-809","consensus_level":"medium","plddt":95.2755,"start":463,"end":809}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35913","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35913-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35913-F1-predicted_aligned_error_v6.png","plddt_mean":89.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDE6B","jax_strain_url":"https://www.jax.org/strain/search?query=PDE6B"},"sequence":{"accession":"P35913","fasta_url":"https://rest.uniprot.org/uniprotkb/P35913.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35913/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35913"}},"corpus_meta":[{"pmid":"12410828","id":"PMC_12410828","title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.","date":"2002","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12410828","citation_count":570,"is_preprint":false},{"pmid":"12508154","id":"PMC_12508154","title":"Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.","date":"2002","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12508154","citation_count":464,"is_preprint":false},{"pmid":"15341647","id":"PMC_15341647","title":"A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion.","date":"2004","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15341647","citation_count":330,"is_preprint":false},{"pmid":"28928639","id":"PMC_28928639","title":"Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal Degeneration.","date":"2017","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/28928639","citation_count":199,"is_preprint":false},{"pmid":"10816479","id":"PMC_10816479","title":"Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10816479","citation_count":163,"is_preprint":false},{"pmid":"16135231","id":"PMC_16135231","title":"A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis.","date":"2005","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16135231","citation_count":154,"is_preprint":false},{"pmid":"28076757","id":"PMC_28076757","title":"iPSC-Derived Retina Transplants Improve Vision in rd1 End-Stage Retinal-Degeneration Mice.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28076757","citation_count":143,"is_preprint":false},{"pmid":"22562504","id":"PMC_22562504","title":"Long-term characterization of retinal degeneration in rd1 and rd10 mice using spectral domain optical coherence tomography.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22562504","citation_count":123,"is_preprint":false},{"pmid":"21427227","id":"PMC_21427227","title":"Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21427227","citation_count":121,"is_preprint":false},{"pmid":"16405498","id":"PMC_16405498","title":"Calpain is activated in degenerating photoreceptors in the rd1 mouse.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16405498","citation_count":113,"is_preprint":false},{"pmid":"7686364","id":"PMC_7686364","title":"Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7686364","citation_count":113,"is_preprint":false},{"pmid":"21364632","id":"PMC_21364632","title":"Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse.","date":"2010","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/21364632","citation_count":110,"is_preprint":false},{"pmid":"11315164","id":"PMC_11315164","title":"A simple polymerase chain reaction assay for genotyping the retinal degeneration mutation (Pdeb(rd1)) in FVB/N-derived transgenic mice.","date":"2001","source":"Laboratory animals","url":"https://pubmed.ncbi.nlm.nih.gov/11315164","citation_count":106,"is_preprint":false},{"pmid":"8595886","id":"PMC_8595886","title":"Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8595886","citation_count":106,"is_preprint":false},{"pmid":"15314236","id":"PMC_15314236","title":"The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15314236","citation_count":103,"is_preprint":false},{"pmid":"14985319","id":"PMC_14985319","title":"Proliferation of microglia, but not photoreceptors, in the outer nuclear layer of the rd-1 mouse.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/14985319","citation_count":98,"is_preprint":false},{"pmid":"21389300","id":"PMC_21389300","title":"Developmental time course distinguishes changes in spontaneous and light-evoked retinal ganglion cell activity in rd1 and rd10 mice.","date":"2011","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/21389300","citation_count":96,"is_preprint":false},{"pmid":"14554249","id":"PMC_14554249","title":"The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization.","date":"2003","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/14554249","citation_count":94,"is_preprint":false},{"pmid":"14573626","id":"PMC_14573626","title":"PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family.","date":"2003","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/14573626","citation_count":94,"is_preprint":false},{"pmid":"7702577","id":"PMC_7702577","title":"Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.","date":"1995","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7702577","citation_count":85,"is_preprint":false},{"pmid":"15039340","id":"PMC_15039340","title":"Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15039340","citation_count":81,"is_preprint":false},{"pmid":"25613321","id":"PMC_25613321","title":"Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25613321","citation_count":79,"is_preprint":false},{"pmid":"17156753","id":"PMC_17156753","title":"CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17156753","citation_count":77,"is_preprint":false},{"pmid":"16163266","id":"PMC_16163266","title":"Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16163266","citation_count":74,"is_preprint":false},{"pmid":"16123450","id":"PMC_16123450","title":"Genotype-phenotype correlation of mouse pde6b mutations.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16123450","citation_count":72,"is_preprint":false},{"pmid":"16275946","id":"PMC_16275946","title":"Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay.","date":"2005","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16275946","citation_count":72,"is_preprint":false},{"pmid":"14679230","id":"PMC_14679230","title":"Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex.","date":"2004","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/14679230","citation_count":71,"is_preprint":false},{"pmid":"25008417","id":"PMC_25008417","title":"Intrinsic bursting of AII amacrine cells underlies oscillations in the rd1 mouse retina.","date":"2014","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/25008417","citation_count":70,"is_preprint":false},{"pmid":"21595874","id":"PMC_21595874","title":"IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.","date":"2011","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21595874","citation_count":70,"is_preprint":false},{"pmid":"18640874","id":"PMC_18640874","title":"Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.","date":"2008","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/18640874","citation_count":68,"is_preprint":false},{"pmid":"19720087","id":"PMC_19720087","title":"Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19720087","citation_count":67,"is_preprint":false},{"pmid":"17962473","id":"PMC_17962473","title":"Activation of endoplasmic reticulum stress in degenerating photoreceptors of the rd1 mouse.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17962473","citation_count":67,"is_preprint":false},{"pmid":"15102765","id":"PMC_15102765","title":"Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15102765","citation_count":66,"is_preprint":false},{"pmid":"11571179","id":"PMC_11571179","title":"Physiological ecology of Clostridium glycolicum RD-1, an aerotolerant acetogen isolated from sea grass roots.","date":"2001","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11571179","citation_count":65,"is_preprint":false},{"pmid":"12547803","id":"PMC_12547803","title":"The refined crystal structure of an eel pout type III antifreeze protein RD1 at 0.62-A resolution reveals structural microheterogeneity of protein and solvation.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12547803","citation_count":62,"is_preprint":false},{"pmid":"24367157","id":"PMC_24367157","title":"Review: the history and role of naturally occurring mouse models with Pde6b mutations.","date":"2013","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/24367157","citation_count":60,"is_preprint":false},{"pmid":"28872643","id":"PMC_28872643","title":"Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina.","date":"2017","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28872643","citation_count":60,"is_preprint":false},{"pmid":"17680823","id":"PMC_17680823","title":"Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.","date":"2007","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17680823","citation_count":60,"is_preprint":false},{"pmid":"11696195","id":"PMC_11696195","title":"Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome.","date":"2001","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11696195","citation_count":59,"is_preprint":false},{"pmid":"11239245","id":"PMC_11239245","title":"Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa.","date":"2001","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/11239245","citation_count":58,"is_preprint":false},{"pmid":"17257436","id":"PMC_17257436","title":"Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study.","date":"2007","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/17257436","citation_count":56,"is_preprint":false},{"pmid":"16319820","id":"PMC_16319820","title":"Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16319820","citation_count":55,"is_preprint":false},{"pmid":"11124530","id":"PMC_11124530","title":"Generalized progressive retinal atrophy of Sloughi dogs is due to an 8-bp insertion in exon 21 of the PDE6B gene.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11124530","citation_count":54,"is_preprint":false},{"pmid":"24489706","id":"PMC_24489706","title":"Network oscillations drive correlated spiking of ON and OFF ganglion cells in the rd1 mouse model of retinal degeneration.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24489706","citation_count":53,"is_preprint":false},{"pmid":"16253986","id":"PMC_16253986","title":"Differential modification of phosducin protein in degenerating rd1 retina is associated with constitutively active Ca2+/calmodulin kinase II in rod outer segments.","date":"2005","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/16253986","citation_count":52,"is_preprint":false},{"pmid":"19596775","id":"PMC_19596775","title":"The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages.","date":"2009","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19596775","citation_count":52,"is_preprint":false},{"pmid":"18400977","id":"PMC_18400977","title":"Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells.","date":"2008","source":"Clinical and vaccine immunology : CVI","url":"https://pubmed.ncbi.nlm.nih.gov/18400977","citation_count":51,"is_preprint":false},{"pmid":"17251487","id":"PMC_17251487","title":"Cellular responses to photoreceptor death in the rd1 mouse model of retinal degeneration.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17251487","citation_count":50,"is_preprint":false},{"pmid":"12296851","id":"PMC_12296851","title":"Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle.","date":"2002","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12296851","citation_count":49,"is_preprint":false},{"pmid":"26961159","id":"PMC_26961159","title":"Carnosic acid slows photoreceptor degeneration in the Pde6b(rd10) mouse model of retinitis pigmentosa.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26961159","citation_count":48,"is_preprint":false},{"pmid":"18854872","id":"PMC_18854872","title":"Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18854872","citation_count":47,"is_preprint":false},{"pmid":"22359480","id":"PMC_22359480","title":"Spontaneous Oscillatory Rhythm in Retinal Activities of Two Retinal Degeneration (rd1 and rd10) Mice.","date":"2011","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22359480","citation_count":47,"is_preprint":false},{"pmid":"26379501","id":"PMC_26379501","title":"Blockade of pathological retinal ganglion cell hyperactivity improves optogenetically evoked light responses in rd1 mice.","date":"2015","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26379501","citation_count":47,"is_preprint":false},{"pmid":"10320645","id":"PMC_10320645","title":"Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene.","date":"1999","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10320645","citation_count":46,"is_preprint":false},{"pmid":"20940301","id":"PMC_20940301","title":"Rod phosphodiesterase-6 PDE6A and PDE6B subunits are enzymatically equivalent.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20940301","citation_count":43,"is_preprint":false},{"pmid":"27067610","id":"PMC_27067610","title":"Neural stem cells transplanted to the subretinal space of rd1 mice delay retinal degeneration by suppressing microglia activation.","date":"2016","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/27067610","citation_count":42,"is_preprint":false},{"pmid":"20238051","id":"PMC_20238051","title":"Do calcium channel blockers rescue dying photoreceptors in the Pde6b ( rd1 ) mouse?","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20238051","citation_count":40,"is_preprint":false},{"pmid":"29472543","id":"PMC_29472543","title":"DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29472543","citation_count":40,"is_preprint":false},{"pmid":"17083330","id":"PMC_17083330","title":"FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis.","date":"2006","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17083330","citation_count":40,"is_preprint":false},{"pmid":"9677330","id":"PMC_9677330","title":"Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9677330","citation_count":40,"is_preprint":false},{"pmid":"31080404","id":"PMC_31080404","title":"Rescue of Retinal Degeneration in rd1 Mice by Intravitreally Injected Metformin.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31080404","citation_count":39,"is_preprint":false},{"pmid":"24045995","id":"PMC_24045995","title":"IQCB1 and PDE6B mutations cause similar early onset retinal degenerations in two closely related terrier dog breeds.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24045995","citation_count":39,"is_preprint":false},{"pmid":"21593549","id":"PMC_21593549","title":"Retinal ganglion cell responses to voltage and current stimulation in wild-type and rd1 mouse retinas.","date":"2011","source":"Journal of neural engineering","url":"https://pubmed.ncbi.nlm.nih.gov/21593549","citation_count":39,"is_preprint":false},{"pmid":"35075486","id":"PMC_35075486","title":"Multiomics analyses reveal early metabolic imbalance and mitochondrial stress in neonatal photoreceptors leading to cell death in Pde6brd1/rd1 mouse model of retinal degeneration.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35075486","citation_count":38,"is_preprint":false},{"pmid":"17044014","id":"PMC_17044014","title":"Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17044014","citation_count":38,"is_preprint":false},{"pmid":"18226199","id":"PMC_18226199","title":"Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.","date":"2008","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18226199","citation_count":37,"is_preprint":false},{"pmid":"23794617","id":"PMC_23794617","title":"PdeB, a cyclic Di-GMP-specific phosphodiesterase that regulates Shewanella oneidensis MR-1 motility and biofilm formation.","date":"2013","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/23794617","citation_count":36,"is_preprint":false},{"pmid":"23255724","id":"PMC_23255724","title":"Functional integrity and modification of retinal dopaminergic neurons in the rd1 mutant mouse: roles of melanopsin and GABA.","date":"2012","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/23255724","citation_count":32,"is_preprint":false},{"pmid":"19833469","id":"PMC_19833469","title":"Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis.","date":"2009","source":"Diagnostic microbiology and infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/19833469","citation_count":31,"is_preprint":false},{"pmid":"16163265","id":"PMC_16163265","title":"Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST?","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16163265","citation_count":30,"is_preprint":false},{"pmid":"33828232","id":"PMC_33828232","title":"Long-term effects of human induced pluripotent stem cell-derived retinal cell transplantation in Pde6b knockout rats.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33828232","citation_count":29,"is_preprint":false},{"pmid":"16184487","id":"PMC_16184487","title":"Effects of the rd1 mutation and host strain on hippocampal learning in mice.","date":"2005","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16184487","citation_count":28,"is_preprint":false},{"pmid":"16503160","id":"PMC_16503160","title":"Up-regulation and increased phosphorylation of protein kinase C (PKC) delta, mu and theta in the degenerating rd1 mouse retina.","date":"2006","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/16503160","citation_count":28,"is_preprint":false},{"pmid":"9003417","id":"PMC_9003417","title":"Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.","date":"1997","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9003417","citation_count":28,"is_preprint":false},{"pmid":"17563719","id":"PMC_17563719","title":"Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17563719","citation_count":27,"is_preprint":false},{"pmid":"15789220","id":"PMC_15789220","title":"Differential Akt activation in the photoreceptors of normal and rd1 mice.","date":"2005","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15789220","citation_count":26,"is_preprint":false},{"pmid":"27416076","id":"PMC_27416076","title":"Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4-/- mouse and bipolar cells in the rd1 mouse and human retina ex vivo.","date":"2016","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27416076","citation_count":26,"is_preprint":false},{"pmid":"31009522","id":"PMC_31009522","title":"Development of a Pde6b Gene Knockout Rat Model for Studies of Degenerative Retinal Diseases.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31009522","citation_count":25,"is_preprint":false},{"pmid":"25489226","id":"PMC_25489226","title":"Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.","date":"2014","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/25489226","citation_count":25,"is_preprint":false},{"pmid":"1329504","id":"PMC_1329504","title":"The search for mutations in the gene for the beta subunit of the cGMP phosphodiesterase (PDEB) in patients with autosomal recessive retinitis pigmentosa.","date":"1992","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1329504","citation_count":24,"is_preprint":false},{"pmid":"24485599","id":"PMC_24485599","title":"Utility of B-cell epitopes based peptides of RD1 and RD2 antigens for immunodiagnosis of pulmonary tuberculosis.","date":"2014","source":"Diagnostic microbiology and infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/24485599","citation_count":23,"is_preprint":false},{"pmid":"18408395","id":"PMC_18408395","title":"Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes.","date":"2008","source":"Medical principles and practice : international journal of the Kuwait University, Health Science Centre","url":"https://pubmed.ncbi.nlm.nih.gov/18408395","citation_count":23,"is_preprint":false},{"pmid":"33673512","id":"PMC_33673512","title":"Clinical Phenotype of PDE6B-Associated Retinitis Pigmentosa.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33673512","citation_count":22,"is_preprint":false},{"pmid":"30670544","id":"PMC_30670544","title":"The GGDEF Domain of the Phosphodiesterase PdeB in Shewanella putrefaciens Mediates Recruitment by the Polar Landmark Protein HubP.","date":"2019","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/30670544","citation_count":22,"is_preprint":false},{"pmid":"16374054","id":"PMC_16374054","title":"rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.","date":"2005","source":"Ophthalmic research","url":"https://pubmed.ncbi.nlm.nih.gov/16374054","citation_count":22,"is_preprint":false},{"pmid":"26283863","id":"PMC_26283863","title":"Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice.","date":"2015","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/26283863","citation_count":22,"is_preprint":false},{"pmid":"26602835","id":"PMC_26602835","title":"Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26602835","citation_count":21,"is_preprint":false},{"pmid":"24593181","id":"PMC_24593181","title":"Cyr61 activates retinal cells and prolongs photoreceptor survival in rd1 mouse model of retinitis pigmentosa.","date":"2014","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24593181","citation_count":21,"is_preprint":false},{"pmid":"8004102","id":"PMC_8004102","title":"Gene for autosomal dominant congenital stationary night blindness maps to the same region as the gene for the beta-subunit of the rod photoreceptor cGMP phosphodiesterase (PDEB) in chromosome 4p16.3.","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8004102","citation_count":20,"is_preprint":false},{"pmid":"37407519","id":"PMC_37407519","title":"Alleviation of Photoreceptor Degeneration Based on Fullerenols in rd1 Mice by Reversing Mitochondrial Dysfunction via Modulation of Mitochondrial DNA Transcription and Leakage.","date":"2023","source":"Small (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37407519","citation_count":19,"is_preprint":false},{"pmid":"17069800","id":"PMC_17069800","title":"Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse.","date":"2006","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/17069800","citation_count":19,"is_preprint":false},{"pmid":"16757583","id":"PMC_16757583","title":"An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.","date":"2006","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16757583","citation_count":19,"is_preprint":false},{"pmid":"31481030","id":"PMC_31481030","title":"Spatio-temporal characterization of S- and M/L-cone degeneration in the Rd1 mouse model of retinitis pigmentosa.","date":"2019","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31481030","citation_count":18,"is_preprint":false},{"pmid":"28404878","id":"PMC_28404878","title":"Activation of liver X receptor delayed the retinal degeneration of rd1 mice through modulation of the immunological function of glia.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28404878","citation_count":18,"is_preprint":false},{"pmid":"16484842","id":"PMC_16484842","title":"Identification of transcriptionally active open reading frames within the RD1 genomic segment of Mycobacterium tuberculosis.","date":"2006","source":"Medical principles and practice : international journal of the Kuwait University, Health Science Centre","url":"https://pubmed.ncbi.nlm.nih.gov/16484842","citation_count":18,"is_preprint":false},{"pmid":"18326735","id":"PMC_18326735","title":"rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18326735","citation_count":18,"is_preprint":false},{"pmid":"14632649","id":"PMC_14632649","title":"Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis.","date":"2003","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14632649","citation_count":17,"is_preprint":false},{"pmid":"25355966","id":"PMC_25355966","title":"Spontaneous oscillatory activity in rd1 mouse retina is transferred from ON pathway to OFF pathway via glycinergic synapse.","date":"2014","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/25355966","citation_count":16,"is_preprint":false},{"pmid":"19114044","id":"PMC_19114044","title":"Enzymatic characteristics of two novel Myxococcus xanthus enzymes, PdeA and PdeB, displaying 3',5'- and 2',3'-cAMP phosphodiesterase, and phosphatase activities.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19114044","citation_count":15,"is_preprint":false},{"pmid":"30643804","id":"PMC_30643804","title":"Lutein and Zeaxanthin Isomers Reduce Photoreceptor Degeneration in the Pde6b  Mouse Model of Retinitis Pigmentosa.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/30643804","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56083,"output_tokens":4256,"usd":0.116044,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11524,"output_tokens":3311,"usd":0.070197,"stage2_stop_reason":"end_turn"},"total_usd":0.186241,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking through the abstracts, I need to identify papers about the canonical PDE6B protein (the beta subunit of rod cGMP phosphodiesterase 6, involved in phototransduction and retinal degeneration).\n\nI need to exclude:\n- Papers about Mycobacterium tuberculosis RD1 locus (papers 1, 2, 3, 5, 6, 9, 15, 18, 19, 21, 26, 27, 29, 30, 33, 38, 39, 41, 46, 47, 49, 54, 87, 92, 95, 97)\n- Papers about rat PDE4A/RD1 cAMP phosphodiesterase (papers 11, 20, 60, 74) - these are about PDE4A, NOT PDE6B\n- Papers about antifreeze protein RD1 (paper 35)\n- Papers about bacterial PdeB (papers 67, 84, 99)\n- Papers about Clostridium RD-1 (paper 34)\n- Clinical/phenotypic description papers with no molecular mechanism\n- Papers that are purely phenotypic descriptions of rd1 mice without establishing mechanism about PDE6B protein itself\n\nPapers with mechanistic findings about PDE6B:\n- Paper 55: Rod PDE6A and PDE6B are enzymatically equivalent\n- Paper 65: H258N mutation in PDE6B - shows increased cGMP hydrolysis, PDE6gamma inhibition blocked\n- Paper 45: Differential phosducin phosphorylation in rd1, linked to CaMKII activation\n- Paper 10: Calpain activation in rd1 photoreceptors\n- Paper 64: Multiomics - early mitochondrial stress and metabolic imbalance in Pde6brd1/rd1\n- Paper 22: GPR179 mutation prevents full restoration of vision after PDE6B gene therapy\n- Paper 14: Compound heterozygous mutations in PDE6B causing arRP\n- Paper 43: 8-bp insertion in PDE6B causing gPRA in Sloughi dogs\n- Paper 62: 3-base deletion in PDE6B exon 21 causing crd1 in dogs\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"PDE6A and PDE6B catalytic subunits are enzymatically equivalent: chimeric homodimeric enzymes containing the PDE6A or PDE6B catalytic domain (expressed in transgenic Xenopus laevis) hydrolyzed cGMP with similar Km (~20–23 µM) and kcat (~4200–5100 s⁻¹) values, and were similarly inhibited by both cone- and rod-specific Pγ subunits. Both were fully activated by recombinant cone transducin-α and native rod Gαt1. In contrast, bovine rod PDE6 heterodimer required markedly higher transducin concentrations for half-maximal activation, indicating the PDE6A/PDE6B heterodimer differs from PDE6C homodimers specifically in its interaction with transducin, not in its catalytic properties or Pγ interactions.\",\n      \"method\": \"Transgenic Xenopus laevis expression of chimeric EGFP-PDE6C-A and EGFP-PDE6C-B; selective immunoprecipitation; in vitro cGMP hydrolysis assays; kinetic analysis (Km, kcat); inhibition assays with Pγ subunits; activation assays with Gαt1 and Gαt2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic reconstitution with kinetic characterization, multiple orthogonal assays (Km, kcat, Pγ inhibition, transducin activation), in vivo expression in transgenic animals\",\n      \"pmids\": [\"20940301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The H258N missense mutation in PDE6B causes congenital stationary night blindness (CSNB) rather than progressive retinitis pigmentosa. Transgenic mice carrying H258N showed an approximately 3-fold increase in cGMP hydrolysis rate (from 130.1 to 319.2 nmol·min⁻¹·nmol⁻¹ rhodopsin in dark-adapted retinas), consistent with the hypothesis that the H258N mutation blocks inhibition of PDE6B activity by the regulatory PDE6γ subunit. ERG phenotype (selective loss of b-wave with relatively normal a-wave) mirrored that of human CSNB patients.\",\n      \"method\": \"Transgenic mouse generation (H258N allele); dark-adapted cGMP-PDE6 enzymatic activity assay on retinal homogenates; electroretinography; histology and photoreceptor cell counting\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic assay with quantitative measurement, transgenic model with functional ERG validation, mechanistic interpretation supported by biochemical and physiological data\",\n      \"pmids\": [\"17044014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In rd1 mouse retinas, phosducin (a regulator of G-protein signaling in photoreceptors) shows aberrant hyperphosphorylation irrespective of light/dark status, in contrast to wild-type retinas where phosducin is highly phosphorylated only in the dark. This hyperphosphorylation coincides with constitutive activation of Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) in rd1 rod outer segments. The elevated CaMKII activity is consistent with the known increase in intracellular calcium caused by the Pde6b mutation (failure to hydrolyze cGMP → persistent opening of cGMP-gated channels → Ca²⁺ overload), implicating CaMKII overactivation as an early step in photoreceptor degeneration.\",\n      \"method\": \"2D gel electrophoresis proteomics; mass spectrometry protein identification; immunoblotting with phospho-specific antibodies; immunohistochemistry; light/dark adaptation experiments in rd1 and wild-type mice\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (proteomics, immunoblotting, IHC, light/dark paradigm) in a single lab; mechanistic link to elevated calcium from Pde6b mutation is inferred but biochemically consistent\",\n      \"pmids\": [\"16253986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Calpain protease is activated in degenerating rd1 photoreceptors at postnatal day 13, coinciding with peak photoreceptor cell death. Calpastatin (endogenous calpain inhibitor) expression is reduced in rd1 retinas, while calpain activity is substantially elevated, demonstrable by an enzymatic in situ assay. Calpain-specific inhibitors decreased calpain activity in situ, implicating calcium-dependent calpain activation as a mediator of photoreceptor cell death downstream of the elevated intracellular Ca²⁺ caused by loss of PDE6B-mediated cGMP hydrolysis.\",\n      \"method\": \"Microarray transcriptome analysis; immunofluorescence; immunoblotting; in situ enzymatic calpain activity assay; pharmacological inhibition with calpain inhibitors\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic activity assay with pharmacological intervention, multiple methods (microarray, IHC, western blot, in situ assay), single lab\",\n      \"pmids\": [\"16405498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A confounding mutation in Gpr179 (encoding a G-protein coupled receptor on ON-bipolar cell dendrites) in the rd1 mouse strain prevents full restoration of the ERG b-wave after AAV-mediated PDE6B gene supplementation. After backcrossing rd1 mice onto a C57BL/6 background to eliminate the Gpr179 mutation, gene replacement of PDE6B restored both the photoreceptor-mediated a-wave and the bipolar cell-mediated b-wave, with preservation for up to 13 months. This demonstrates that PDE6B gene therapy can rescue both photoreceptor function and downstream bipolar cell signaling when no secondary mutations are present.\",\n      \"method\": \"AAV-mediated gene therapy in rd1 mice; electroretinography (a-wave and b-wave measurement); genetic backcrossing; Sanger sequencing/genotyping for Gpr179 mutation; in vivo longitudinal follow-up\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function/gain-of-function genetic experiment with defined molecular and functional phenotypic readout; gene replacement with long-term ERG follow-up; replicated across genetic backgrounds\",\n      \"pmids\": [\"25613321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Two probands with autosomal recessive retinitis pigmentosa were found to carry compound heterozygous mutations in the PDE6B gene: one with Gly576Asp and His620(1-bp deletion), the other with Lys706X (nonsense) and an AG→AT splice acceptor site mutation in intron 2. These are the first mutations in the human PDE6B gene established as causative for autosomal recessive RP, confirming PDE6B as a disease gene for this condition.\",\n      \"method\": \"Haplotype analysis with dinucleotide repeat polymorphism; DGGE and SSCP electrophoresis of all 22 PDE6B exons; DNA sequencing; cosegregation analysis in families\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cosegregation of compound heterozygous mutations with disease in two independent families; multiple mutation types including a nonsense mutation; single lab\",\n      \"pmids\": [\"8595886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A null mutation (8-bp insertion after codon 816) in the PDE6B gene cosegregates with generalized progressive retinal atrophy (gPRA) in Sloughi dogs, establishing PDE6B mutation as the cause of this canine retinal degeneration. PDE6B was excluded as a candidate gene for gPRA in 11 other dog breeds by detecting heterozygous allele constellations in affected animals.\",\n      \"method\": \"Genomic library isolation of canine PDE6B; SSCP analysis; cosegregation analysis in a large Sloughi pedigree; exclusion analysis in 11 other breeds\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutation cosegregation in large pedigree, functional inference from insertion causing frameshift; single lab\",\n      \"pmids\": [\"11124530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A 3-base deletion in exon 21 of canine PDE6B causes early-onset retinal degeneration (crd1) in American Staffordshire Terriers, with structural photoreceptor abnormalities detectable as early as 11 weeks of age affecting both rod and cone inner and outer segments. This was identified by GWAS mapping to CFA3 followed by candidate gene sequencing.\",\n      \"method\": \"GWAS with Illumina Canine SNP array; candidate gene sequencing; retinal morphology by light microscopy; PLINK association analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GWAS plus direct sequencing with cosegregation; histological phenotype characterization; single lab\",\n      \"pmids\": [\"24045995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Multiomics analysis of neonatal and developing Pde6brd1/rd1 rods before the onset of degeneration revealed early downregulation of anabolic and energy metabolism genes, early changes in calcium signaling and oxidative phosphorylation (with specific partial bypass of complex I electron transfer), and dysregulation of glycolysis, pentose phosphate, and purine biosynthesis pathways. Transmission electron microscopy and ex vivo oxygen consumption assays validated progressive mitochondrial structural abnormalities and functional deficits in rd1 rods. Aberrant calcium signaling is implicated as an initiator of mitochondrial stress, establishing mitochondrial damage and metabolic disruption as early drivers of photoreceptor cell death caused by PDE6B loss.\",\n      \"method\": \"Transcriptome profiling (RNA-seq) of neonatal/developing rods; quantitative proteomics; metabolomics; transmission electron microscopy; ex vivo oxygen consumption assays; temporal analysis before onset of degeneration\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal omics methods plus ultrastructural and functional validation, temporal analysis preceding cell death onset, mechanistic pathway placement\",\n      \"pmids\": [\"35075486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HDAC class I/II overactivation temporally precedes photoreceptor degeneration in rd1 retinas. Using a custom in situ HDAC activity assay, histone acetylation was found dramatically reduced in degenerating rd1 photoreceptors. Pharmacological inhibition of HDAC I/II activity in rd1 organotypic retinal explants decreased PARP activity and strongly reduced photoreceptor cell death, establishing excessive HDAC activation as a mechanistically important step in the cell death pathway downstream of PDE6B loss.\",\n      \"method\": \"Custom in situ HDAC activity assay; immunofluorescence for histone acetylation; pharmacological HDAC I/II inhibition in organotypic retinal explants; PARP activity assay; TUNEL cell death quantification\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in situ enzymatic assay, pharmacological intervention with defined molecular and cellular readout, organotypic explant system; single lab\",\n      \"pmids\": [\"21364632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A missense mutation p.W807R in the PDE6B gene was identified and shown to cosegregate with autosomal recessive retinitis pigmentosa in a consanguineous Tunisian family, distinct from USH2 syndrome in the same family caused by a GPR98 mutation. This demonstrates that W807R in PDE6B is a pathogenic variant causing non-syndromic arRP.\",\n      \"method\": \"Linkage analysis with flanking PDE6B markers (D4S3360 and D4S2930); molecular sequencing; cosegregation analysis in an extended consanguineous family\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cosegregation with flanking markers and direct sequencing; single lab, single family\",\n      \"pmids\": [\"18854872\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDE6B encodes the beta catalytic subunit of rod photoreceptor cGMP phosphodiesterase 6 (PDE6), which is enzymatically equivalent to PDE6A in catalytic properties and Pγ-subunit interactions but differs in transducin interaction; loss-of-function mutations abolish cGMP hydrolysis in the phototransduction cascade, leading to cGMP accumulation, persistent cGMP-gated channel opening, calcium overload, constitutive CaMKII activation, aberrant phosducin hyperphosphorylation, calpain activation, HDAC overactivation, and early mitochondrial stress/metabolic disruption that collectively drive rod photoreceptor apoptosis; gain-of-function H258N mutation blocks PDE6γ inhibition, causing CSNB; and AAV-mediated PDE6B gene replacement restores both photoreceptor and bipolar cell function when confounding secondary mutations are absent.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDE6B encodes the beta catalytic subunit of rod photoreceptor cGMP phosphodiesterase, the effector enzyme of the phototransduction cascade that hydrolyzes cGMP to terminate the light response [#0]. The PDE6B catalytic domain is enzymatically equivalent to PDE6A—reconstituted chimeric homodimers hydrolyze cGMP with comparable Km and kcat and are similarly inhibited by the regulatory Pγ subunit and activated by transducin-α—with the rod PDE6A/PDE6B heterodimer distinguished from cone PDE6C chiefly by its requirement for higher transducin concentrations for activation [#0]. Loss-of-function mutations in PDE6B cause autosomal recessive retinitis pigmentosa in humans and analogous retinal degenerations in dogs, with disease-causing nonsense, frameshift, splice, and missense alleles identified across multiple families and breeds [#5, #6, #7, #10]. Failure to hydrolyze cGMP keeps cGMP-gated channels open, producing calcium overload that drives a cascade of downstream effectors—constitutive CaMKII activation with aberrant phosducin hyperphosphorylation [#2], calpain protease activation with reduced calpastatin [#3], class I/II HDAC overactivation that precedes cell death [#9], and early mitochondrial structural and metabolic disruption [#8]—that collectively execute photoreceptor apoptosis. In contrast, the gain-of-function H258N mutation increases cGMP hydrolysis ~3-fold by blocking Pγ inhibition and causes congenital stationary night blindness rather than progressive degeneration [#1]. AAV-mediated PDE6B gene replacement restores both the photoreceptor a-wave and the bipolar-cell b-wave when confounding secondary mutations are absent [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing PDE6B as a human disease gene answered whether mutations in the rod PDE beta subunit are causative for inherited retinal degeneration.\",\n      \"evidence\": \"DGGE/SSCP screening and sequencing of all 22 exons with cosegregation in two arRP families carrying compound heterozygous mutations\",\n      \"pmids\": [\"8595886\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional demonstration of how each allele impairs cGMP hydrolysis\", \"Single lab, two families\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"A null frameshift allele cosegregating with canine gPRA confirmed PDE6B loss-of-function as causative across species and validated a large-animal model.\",\n      \"evidence\": \"SSCP and cosegregation analysis in a Sloughi pedigree plus exclusion in 11 other breeds\",\n      \"pmids\": [\"11124530\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical characterization of the truncated protein\", \"Breed-specific allele\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying aberrant phosducin hyperphosphorylation and constitutive CaMKII activation began to define the calcium-driven signaling consequences of PDE6B loss.\",\n      \"evidence\": \"2D-gel proteomics, mass spectrometry, phospho-immunoblotting and IHC with light/dark adaptation in rd1 versus wild-type mice\",\n      \"pmids\": [\"16253986\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link to elevated calcium inferred, not directly perturbed\", \"Causal role in cell death not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating calpain activation downstream of calcium overload identified a protease effector arm of the degeneration pathway.\",\n      \"evidence\": \"In situ enzymatic calpain assay with calpastatin measurement and pharmacological calpain inhibition in rd1 retinas\",\n      \"pmids\": [\"16405498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Inhibition reduced activity but rescue of cell survival not quantified here\", \"Calpain substrates in photoreceptors not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The H258N transgenic model resolved why one PDE6B allele causes stationary night blindness rather than progressive RP—by showing a gain-of-function increase in cGMP hydrolysis.\",\n      \"evidence\": \"Transgenic mice with dark-adapted cGMP-PDE enzymatic assays, ERG, and histology\",\n      \"pmids\": [\"17044014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of impaired Pγ inhibition not resolved\", \"Mechanism of selective b-wave loss not detailed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"In vitro reconstitution of chimeric catalytic domains established that PDE6A and PDE6B are catalytically equivalent and that the rod enzyme differs from cone PDE6 in transducin interaction, not catalysis or Pγ regulation.\",\n      \"evidence\": \"Transgenic Xenopus expression of EGFP-PDE6C-A/-B chimeras with kinetic (Km, kcat), Pγ inhibition, and transducin activation assays\",\n      \"pmids\": [\"20940301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the transducin interaction difference unknown\", \"Behavior of the native A/B heterodimer versus chimeric homodimers\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing HDAC class I/II overactivation preceding cell death and rescuable by HDAC inhibition placed epigenetic dysregulation within the degeneration cascade.\",\n      \"evidence\": \"Custom in situ HDAC activity assay, histone acetylation IHC, and pharmacological HDAC inhibition in rd1 organotypic explants with PARP and TUNEL readouts\",\n      \"pmids\": [\"21364632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific HDAC isoform and target genes not identified\", \"Connection to upstream calcium signaling not directly tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A canine exon-21 deletion causing early-onset rod and cone degeneration extended the disease spectrum of PDE6B mutations to early structural photoreceptor defects.\",\n      \"evidence\": \"GWAS mapping to CFA3, candidate sequencing, and retinal morphology in American Staffordshire Terriers\",\n      \"pmids\": [\"24045995\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Why a rod-PDE gene defect affects cone segments not mechanistically explained\", \"No biochemical assay of the mutant protein\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"AAV gene replacement demonstrated PDE6B therapeutic rescue and clarified that a confounding Gpr179 mutation, not the therapy, limited bipolar-cell recovery.\",\n      \"evidence\": \"AAV-PDE6B supplementation in rd1 mice with a- and b-wave ERG, genetic backcrossing to remove Gpr179, and 13-month longitudinal follow-up\",\n      \"pmids\": [\"25613321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Durability and dosing in larger eyes not addressed\", \"Therapeutic window relative to degeneration stage not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Pre-degeneration multiomics established that mitochondrial stress and metabolic disruption are early drivers, not late consequences, of PDE6B loss.\",\n      \"evidence\": \"RNA-seq, proteomics, metabolomics, transmission EM, and ex vivo oxygen consumption in neonatal/developing rd1 rods before degeneration onset\",\n      \"pmids\": [\"35075486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal sequence from calcium signaling to mitochondrial failure not directly perturbed\", \"Whether metabolic intervention prevents degeneration not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the parallel calcium-dependent effector arms (CaMKII/phosducin, calpain, HDAC, mitochondrial/metabolic) are causally ordered and integrated into the final apoptotic decision remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No epistatic test ranking the effector pathways\", \"No structural model of the PDE6A/PDE6B/Pγ/transducin assembly in the timeline\", \"Translation of combined-pathway intervention to therapy unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"complexes\": [\"Rod cGMP phosphodiesterase 6 (PDE6) holoenzyme\"],\n    \"partners\": [\"PDE6A\", \"PDE6G\", \"GNAT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}